Mindestbestellung 120 EUR Kostenlose Lieferung ab 250 EUR Bereit zur Abholung dead drop: in 5 Min. abholen Kostenloser Versand ab 250 EUR Aktionen

Substanzen · Benzodiazepine und Thienodiazepine

Diclazepam

C16H12Cl2N2O CAS 2894-68-0 Nur für analytische Forschungszwecke — nicht für den menschlichen Verzehr
Bevorzugter Name
Diclazepam
IUPAC-Name
7-chloro-5-(2-chlorophenyl)-1-methyl-3H-1,4-benzodiazepin-2-one
CAS-Nummer der Stammverbindung (Referenz)
2894-68-0
Summenformel
C16H12Cl2N2O
Molekulargewicht
319.2 g/mol
InChIKey
VPAYQWRBBOGGPY-UHFFFAOYSA-N
PubChem
CID 76168
Quelle
PubChem
Geprüfte Synonyme und Katalogkürzel
2'-Chlorodiazepam Ro 5-3448 Chlorodiazepam

Passende Artikel im aktuellen Shop-Katalog

Geprüftes Pharmakologie- & Toxikologie-Dossier

Diclazepam

Long-Acting Chlorinated Diazepam Analogue (GABA-A PAM) 1,4-Benzodiazepine
Geprüfte PubChem- & CAS-Identität C16H12Cl2N2O · CAS 2894-68-0 · CID 76168
Kalibrierte Lieferform Präzisionstabletten · 1 Tablette = 1 mg
≥98 % analytische Reinheit geprüft 319.2 g/mol
WHO-, PubMed- & PubChem-Quellen 2 cited records

Rezeptor-Telemetrie & Wirkmechanismus

GABAₐ α₂/α₃ Anxiolysis & Myorelaxation High PAM
GABAₐ α₁ Hypnotic / Sedative Drive Moderate-High
GABAₐ α₅ Amnestic / Cognitive Modulation Moderate

2'-Chlorodiazepam acting at classical benzodiazepine GABA-A sites with ~8–10x the milligram potency of diazepam (~1 mg diclazepam ≈ 10 mg diazepam).

Biotransformation & Active Metabolites

Human metabolism (Moosmann et al.) yields three active pharmaceutical metabolites: delorazepam, lorazepam, and lormetazepam (T1/2 ~42 h).

Zeitliche Pharmakokinetik

Long-Acting Chlorinated Diazepam Analogue (GABA-A PAM) — 1 tablet = 1 mg equals roughly 10 mg diazepam in literature; subtle, non-intoxicating perceived feel masks strong motor impairment and multi-day active metabolite accumulation.

  1. Onset 30–75 min
  2. Peak Window 2–4 h
  3. Total Window 8–12 h
  4. Residual / Half-Life 24–48 h active metabolite tail (T1/2 ~42 h)

1 tablet = 1 mg equals roughly 10 mg diazepam in literature; subtle, non-intoxicating perceived feel masks strong motor impairment and multi-day active metabolite accumulation.

Quantitatives Wirkungsspektrum (Literaturdaten)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
0.5 mg
Cognitive & Sensory

Subtle threshold receptor activity (Long-Acting Chlorinated Diazepam Analogue (GABA-A PAM)).

Somatic & Autonomic

Minimal baseline autonomic shift.

Light
0.5–1 mg
Cognitive & Sensory

Mild, clear-headed expression of primary class profile.

Somatic & Autonomic

Light somatic modulation.

Common Reference
1–2 mg
Cognitive & Sensory

Full characteristic neurochemical and perceptual profile documented in literature.

Somatic & Autonomic

Moderate somatic relaxation, ataxia, or autonomic tone depending on class.

Strong
2–4 mg
Cognitive & Sensory

Pronounced intensity, cognitive/motor impairment, or deep immersion.

Somatic & Autonomic

Marked somatic load and heightened adverse-event sensitivity.

Heavy / Toxic Zone
5+ mg
Cognitive & Sensory

Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.

Somatic & Autonomic

High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.

Wechselwirkungsmatrix — Niemals kombinieren

Lebensgefahr — Niemals kombinieren

Opioids (O-DSMT, tramadol, morphine, oxycodone, fentanyl)

Synergistic brainstem respiratory depression causing unconsciousness and fatal respiratory arrest.

Alcohol, GHB/GBL, and Barbiturates

Extreme CNS depression, complete anterograde amnesia, loss of airway reflexes, and fatal aspiration.

Hohes Risiko — Vermeiden

Dissociatives (Ketamine, 2-FDCK, DCK, O-PCE, MXE)

Unpredictable sedation, severe motor ataxia, blackout, and emesis aspiration hazard.

Vorsicht / Abschwächung

CYP3A4 inhibitors (grapefruit juice, ketoconazole) & Stimulants

CYP3A4 inhibitors prolong plasma half-life; stimulants mask sedation until they wear off.

Isomeren- & Strukturvergleich

1 tablet = 1 mg equals roughly 10 mg diazepam in literature; subtle, non-intoxicating perceived feel masks strong motor impairment and multi-day active metabolite accumulation.

Stabilität & Lagerung

Form: Precision-pressed 1 mg analytical tablets (1 tablet = 1 mg). · Parent molecule soluble in ethanol, propylene glycol, and DMSO; sparingly soluble in water.

Store sealed in a cool, dry, light-protected container away from humidity.

Cross-Tolerance & Dependence Profile

Complete cross-tolerance across all GABA-A benzodiazepines/thienodiazepines. Rapid physical dependence develops with continuous daily exposure; abrupt cessation after prolonged intake can trigger life-threatening rebound seizures and delirium.

Analytische & toxikologische Monographie

Diclazepam (7-chloro-5-(2-chlorophenyl)-1-methyl-3H-1,4-benzodiazepin-2-one; CAS 2894-68-0, PubChem CID 76168) is a 1,4-benzodiazepine reference compound (C16H12Cl2N2O, 319.2 g/mol) classified pharmacologically as a Long-Acting Chlorinated Diazepam Analogue (GABA-A PAM). 2'-Chlorodiazepam acting at classical benzodiazepine GABA-A sites with ~8–10x the milligram potency of diazepam (~1 mg diclazepam ≈ 10 mg diazepam). Human metabolism (Moosmann et al.) yields three active pharmaceutical metabolites: delorazepam, lorazepam, and lormetazepam (T1/2 ~42 h). In published observational and toxicological literature, threshold response is noted at 0.5 mg, light range at 0.5–1 mg, common reference range at 1–2 mg, strong intensity at 2–4 mg, and heavy/adverse territory at 5+ mg, with an onset of 30–75 min, peak window of 2–4 h, and total duration of 8–12 h (24–48 h active metabolite tail (T1/2 ~42 h)). 1 tablet = 1 mg equals roughly 10 mg diazepam in literature; subtle, non-intoxicating perceived feel masks strong motor impairment and multi-day active metabolite accumulation. Critical contraindications include Opioids (O-DSMT, tramadol, morphine, oxycodone, fentanyl), Alcohol, GHB/GBL, and Barbiturates.

Chemische Struktur und Molekülprofil

Diclazepam (7-chloro-5-(2-chlorophenyl)-1-methyl-3H-1,4-benzodiazepin-2-one) ist eine Referenzverbindung aus der Stoffklasse Benzodiazepine und Thienodiazepine mit der Summenformel C16H12Cl2N2O und einer molaren Masse von 319.2 g/mol. Die Stammverbindung wird unter der CAS-Nummer 2894-68-0 sowie in der NCBI-PubChem-Datenbank unter CID 76168 geführt (Standard-InChIKey: VPAYQWRBBOGGPY-UHFFFAOYSA-N).

Quellen

Referenztoxikologie und Sicherheitsprofil

Laut dokumentierten Referenzdaten (PubChem / PsychonautWiki, CC BY 4.0) gehört Diclazepam zur chemischen Klasse Benzodiazepines. Toxikologische Hinweise (PsychonautWiki): geringe Eigen-Toxizität; Kombinationen mit Depressiva (Alkohol, Opioide) sind lebensgefährlich. Abhängigkeitspotenzial (PsychonautWiki): sehr hohes physisches und psychisches Abhängigkeitspotenzial. Dokumentierte Kreuztoleranz: GABAergic. Beim Umgang im Labor sind geeignete persönliche Schutzausrüstung und das Sicherheitsdatenblatt (SDB) zu beachten.

Quellen

Analytischer Verwendungszweck und Laborhinweis

Dieses Datenblatt dient ausschließlich der chemischen, analytischen und toxikologischen Dokumentation. Das Material ist nicht für den menschlichen Verzehr bestimmt. Ein Forschungshinweis begründet keinen Rechtsstatus.

Quellen